0
Medical researchers are striving to fast-track the development of innovative Tuberculosis (TB) treatments. They have announced the start of a phase 2B/C clinical trial program. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered.